News Headlines Article

FDA clears Vertex’s hepatitis C drug Incivek
Monterey Herald

The Food and Drug Administration approved Vertex Pharmaceuticals Inc.’s hepatitis C drug Incivek Monday, making it the second new treatment to be approved in the last two weeks.

Incivek is a highly-anticipated pill that is expected to have annual sales in the billions. It is approved for patients who have some liver damage from hepatitis C who either have not been treated, or were not cured by other drugs. Patients on Incivek take two pills three times per day.